We've found
14,731
archived clinical trials in
Psychiatric
We've found
14,731
archived clinical trials in
Psychiatric
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Updated: 12/8/2015
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated: 12/8/2015
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Updated: 12/8/2015
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated: 12/8/2015
Click here to add this to my saved trials
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Updated: 12/8/2015
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated: 12/8/2015
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Updated: 12/8/2015
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated: 12/8/2015
Click here to add this to my saved trials
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Updated: 12/8/2015
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated: 12/8/2015
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Updated: 12/8/2015
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated: 12/8/2015
Click here to add this to my saved trials
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Updated: 12/8/2015
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated: 12/8/2015
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Updated: 12/8/2015
A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Status: Enrolling
Updated: 12/8/2015
Click here to add this to my saved trials
Parent-delivered Massage for Children With Autism
Updated: 12/8/2015
Phase 2 Study of the Parent-delivered Massage Treatment Protocol for Children With Autism
Status: Enrolling
Updated: 12/8/2015
Parent-delivered Massage for Children With Autism
Updated: 12/8/2015
Phase 2 Study of the Parent-delivered Massage Treatment Protocol for Children With Autism
Status: Enrolling
Updated: 12/8/2015
Click here to add this to my saved trials
Parent-delivered Massage for Children With Autism
Updated: 12/8/2015
Phase 2 Study of the Parent-delivered Massage Treatment Protocol for Children With Autism
Status: Enrolling
Updated: 12/8/2015
Parent-delivered Massage for Children With Autism
Updated: 12/8/2015
Phase 2 Study of the Parent-delivered Massage Treatment Protocol for Children With Autism
Status: Enrolling
Updated: 12/8/2015
Click here to add this to my saved trials
Parent-delivered Massage for Children With Autism
Updated: 12/8/2015
Phase 2 Study of the Parent-delivered Massage Treatment Protocol for Children With Autism
Status: Enrolling
Updated: 12/8/2015
Parent-delivered Massage for Children With Autism
Updated: 12/8/2015
Phase 2 Study of the Parent-delivered Massage Treatment Protocol for Children With Autism
Status: Enrolling
Updated: 12/8/2015
Click here to add this to my saved trials
Parent-delivered Massage for Children With Autism
Updated: 12/8/2015
Phase 2 Study of the Parent-delivered Massage Treatment Protocol for Children With Autism
Status: Enrolling
Updated: 12/8/2015
Parent-delivered Massage for Children With Autism
Updated: 12/8/2015
Phase 2 Study of the Parent-delivered Massage Treatment Protocol for Children With Autism
Status: Enrolling
Updated: 12/8/2015
Click here to add this to my saved trials
Group vs. Individual Cognitive Processing Therapy for Combat-related PTSD
Updated: 12/8/2015
Group vs. Individual Cognitive Processing Therapy for Combat-related PTSD
Status: Enrolling
Updated: 12/8/2015
Group vs. Individual Cognitive Processing Therapy for Combat-related PTSD
Updated: 12/8/2015
Group vs. Individual Cognitive Processing Therapy for Combat-related PTSD
Status: Enrolling
Updated: 12/8/2015
Click here to add this to my saved trials
Parent-delivered Massage for Children With Autism - Ages 6 to 11
Updated: 12/8/2015
Phase 1 Study of the Parent-delivered Massage Treatment Protocol for Children With Autism Ages 6 to 11
Status: Enrolling
Updated: 12/8/2015
Parent-delivered Massage for Children With Autism - Ages 6 to 11
Updated: 12/8/2015
Phase 1 Study of the Parent-delivered Massage Treatment Protocol for Children With Autism Ages 6 to 11
Status: Enrolling
Updated: 12/8/2015
Click here to add this to my saved trials
Multimodal Neurodiagnostic Imaging of Traumatic Brain Injury and Post-Traumatic Stress Disorder
Updated: 12/9/2015
Evidence Based Multimodal Neurodiagnostic Imaging of Traumatic Brain Injury and Post-Traumatic Stress Disorder at the Saint Louis University Advanced Neurosurgical Innovation Center (SANIC)
Status: Enrolling
Updated: 12/9/2015
Multimodal Neurodiagnostic Imaging of Traumatic Brain Injury and Post-Traumatic Stress Disorder
Updated: 12/9/2015
Evidence Based Multimodal Neurodiagnostic Imaging of Traumatic Brain Injury and Post-Traumatic Stress Disorder at the Saint Louis University Advanced Neurosurgical Innovation Center (SANIC)
Status: Enrolling
Updated: 12/9/2015
Click here to add this to my saved trials
Family Training Program for Parents of Substance Using Adolescents
Updated: 12/9/2015
CRAFT: Helping Parents Initiate and Support Their Adolescent's Treatment
Status: Enrolling
Updated: 12/9/2015
Family Training Program for Parents of Substance Using Adolescents
Updated: 12/9/2015
CRAFT: Helping Parents Initiate and Support Their Adolescent's Treatment
Status: Enrolling
Updated: 12/9/2015
Click here to add this to my saved trials
Safety, Tolerability, PK & Efficacy of V81444 in Volunteers With Attention Deficit/ Hyperactivity Disorder (ADHD)
Updated: 12/9/2015
A Double-blind, Randomized, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Repeat Oral Doses of V81444 in Volunteers With Attention Deficit / Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/9/2015
Safety, Tolerability, PK & Efficacy of V81444 in Volunteers With Attention Deficit/ Hyperactivity Disorder (ADHD)
Updated: 12/9/2015
A Double-blind, Randomized, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Repeat Oral Doses of V81444 in Volunteers With Attention Deficit / Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/9/2015
Click here to add this to my saved trials
Behavioral Treatment for Children With Conduct Problems and Callous-Unemotional Traits
Updated: 12/10/2015
Designing a Novel Behavioral Treatment Protocol for Children Characterized by Conduct Problems and Callous-unemotional Traits
Status: Enrolling
Updated: 12/10/2015
Behavioral Treatment for Children With Conduct Problems and Callous-Unemotional Traits
Updated: 12/10/2015
Designing a Novel Behavioral Treatment Protocol for Children Characterized by Conduct Problems and Callous-unemotional Traits
Status: Enrolling
Updated: 12/10/2015
Click here to add this to my saved trials
Changes in Quadriceps Function Following Local or Distant Interventions in Individuals With Patellofemoral Pain
Updated: 12/10/2015
Changes in Quadriceps Function Following Local or Distant Interventions in Individuals With Patellofemoral Pain
Status: Enrolling
Updated: 12/10/2015
Changes in Quadriceps Function Following Local or Distant Interventions in Individuals With Patellofemoral Pain
Updated: 12/10/2015
Changes in Quadriceps Function Following Local or Distant Interventions in Individuals With Patellofemoral Pain
Status: Enrolling
Updated: 12/10/2015
Click here to add this to my saved trials
Vilazodone Treatment for Marijuana Dependence
Updated: 12/10/2015
Vilazodone Treatment for Marijuana Dependence
Status: Enrolling
Updated: 12/10/2015
Vilazodone Treatment for Marijuana Dependence
Updated: 12/10/2015
Vilazodone Treatment for Marijuana Dependence
Status: Enrolling
Updated: 12/10/2015
Click here to add this to my saved trials
Effect of Oxytocin on Craving and Therapy Response
Updated: 12/10/2015
Effect of Oxytocin on Craving and Therapy Response in Marijuana-dependent Individuals
Status: Enrolling
Updated: 12/10/2015
Effect of Oxytocin on Craving and Therapy Response
Updated: 12/10/2015
Effect of Oxytocin on Craving and Therapy Response in Marijuana-dependent Individuals
Status: Enrolling
Updated: 12/10/2015
Click here to add this to my saved trials
Treating Chronic Pain in Buprenorphine Patients in Primary Care Settings
Updated: 12/10/2015
Treating Chronic Pain in Buprenorphine Patients in Primary Care Settings
Status: Enrolling
Updated: 12/10/2015
Treating Chronic Pain in Buprenorphine Patients in Primary Care Settings
Updated: 12/10/2015
Treating Chronic Pain in Buprenorphine Patients in Primary Care Settings
Status: Enrolling
Updated: 12/10/2015
Click here to add this to my saved trials
e-Cigarettes Versus NRT Gum for Smoking Cessation
Updated: 12/10/2015
e-Cigarettes Versus Nicotine Replacement Therapy for Smoking Cessation
Status: Enrolling
Updated: 12/10/2015
e-Cigarettes Versus NRT Gum for Smoking Cessation
Updated: 12/10/2015
e-Cigarettes Versus Nicotine Replacement Therapy for Smoking Cessation
Status: Enrolling
Updated: 12/10/2015
Click here to add this to my saved trials
Effects of CPAP Therapy on PTSD Symptoms
Updated: 12/10/2015
Effects of Continuous Positive Airway Pressure Therapy for Obstructive Sleep Apnea on PTSD Symptoms
Status: Enrolling
Updated: 12/10/2015
Effects of CPAP Therapy on PTSD Symptoms
Updated: 12/10/2015
Effects of Continuous Positive Airway Pressure Therapy for Obstructive Sleep Apnea on PTSD Symptoms
Status: Enrolling
Updated: 12/10/2015
Click here to add this to my saved trials
Cognitive Behavior Therapy and Habit Reversal Training for the Treatment of Chronic Tic Disorders in Children
Updated: 12/10/2015
Behavior Therapy for Children With Chronic Tic Disorders
Status: Enrolling
Updated: 12/10/2015
Cognitive Behavior Therapy and Habit Reversal Training for the Treatment of Chronic Tic Disorders in Children
Updated: 12/10/2015
Behavior Therapy for Children With Chronic Tic Disorders
Status: Enrolling
Updated: 12/10/2015
Click here to add this to my saved trials
Cognitive Behavior Therapy and Habit Reversal Training for the Treatment of Chronic Tic Disorders in Children
Updated: 12/10/2015
Behavior Therapy for Children With Chronic Tic Disorders
Status: Enrolling
Updated: 12/10/2015
Cognitive Behavior Therapy and Habit Reversal Training for the Treatment of Chronic Tic Disorders in Children
Updated: 12/10/2015
Behavior Therapy for Children With Chronic Tic Disorders
Status: Enrolling
Updated: 12/10/2015
Click here to add this to my saved trials
Cognitive Behavior Therapy and Habit Reversal Training for the Treatment of Chronic Tic Disorders in Children
Updated: 12/10/2015
Behavior Therapy for Children With Chronic Tic Disorders
Status: Enrolling
Updated: 12/10/2015
Cognitive Behavior Therapy and Habit Reversal Training for the Treatment of Chronic Tic Disorders in Children
Updated: 12/10/2015
Behavior Therapy for Children With Chronic Tic Disorders
Status: Enrolling
Updated: 12/10/2015
Click here to add this to my saved trials
Effect of Oxytocin on Stress in Marijuana Users
Updated: 12/10/2015
Effect of Oxytocin on Stress Response in Marijuana-dependent Individuals
Status: Enrolling
Updated: 12/10/2015
Effect of Oxytocin on Stress in Marijuana Users
Updated: 12/10/2015
Effect of Oxytocin on Stress Response in Marijuana-dependent Individuals
Status: Enrolling
Updated: 12/10/2015
Click here to add this to my saved trials
Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism
Updated: 12/11/2015
Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism
Status: Enrolling
Updated: 12/11/2015
Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism
Updated: 12/11/2015
Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism
Status: Enrolling
Updated: 12/11/2015
Click here to add this to my saved trials
A Randomized Trial of Interventions for Teenage Drivers With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/11/2015
Updated: 12/11/2015
A Randomized Trial of Interventions for Teenage Drivers With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/11/2015
Updated: 12/11/2015
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
Updated: 12/11/2015
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
POC Study in Partially Responsive Generalized Anxiety Disorder
Updated: 12/11/2015
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
Updated: 12/11/2015
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
POC Study in Partially Responsive Generalized Anxiety Disorder
Updated: 12/11/2015
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
Updated: 12/11/2015
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
POC Study in Partially Responsive Generalized Anxiety Disorder
Updated: 12/11/2015
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
Updated: 12/11/2015
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
POC Study in Partially Responsive Generalized Anxiety Disorder
Updated: 12/11/2015
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
Updated: 12/11/2015
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
POC Study in Partially Responsive Generalized Anxiety Disorder
Updated: 12/11/2015
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
Updated: 12/11/2015
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
POC Study in Partially Responsive Generalized Anxiety Disorder
Updated: 12/11/2015
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
Updated: 12/11/2015
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
POC Study in Partially Responsive Generalized Anxiety Disorder
Updated: 12/11/2015
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
Updated: 12/11/2015
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
POC Study in Partially Responsive Generalized Anxiety Disorder
Updated: 12/11/2015
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
Updated: 12/11/2015
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
POC Study in Partially Responsive Generalized Anxiety Disorder
Updated: 12/11/2015
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
Updated: 12/11/2015
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
POC Study in Partially Responsive Generalized Anxiety Disorder
Updated: 12/11/2015
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
Updated: 12/11/2015
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
POC Study in Partially Responsive Generalized Anxiety Disorder
Updated: 12/11/2015
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
Updated: 12/11/2015
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
POC Study in Partially Responsive Generalized Anxiety Disorder
Updated: 12/11/2015
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
Updated: 12/11/2015
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
POC Study in Partially Responsive Generalized Anxiety Disorder
Updated: 12/11/2015
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
Updated: 12/11/2015
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
POC Study in Partially Responsive Generalized Anxiety Disorder
Updated: 12/11/2015
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
Updated: 12/11/2015
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
POC Study in Partially Responsive Generalized Anxiety Disorder
Updated: 12/11/2015
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
Updated: 12/11/2015
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
POC Study in Partially Responsive Generalized Anxiety Disorder
Updated: 12/11/2015
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
Updated: 12/11/2015
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
POC Study in Partially Responsive Generalized Anxiety Disorder
Updated: 12/11/2015
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
Updated: 12/11/2015
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
POC Study in Partially Responsive Generalized Anxiety Disorder
Updated: 12/11/2015
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
Updated: 12/11/2015
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
POC Study in Partially Responsive Generalized Anxiety Disorder
Updated: 12/11/2015
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
Updated: 12/11/2015
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
POC Study in Partially Responsive Generalized Anxiety Disorder
Updated: 12/11/2015
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
Updated: 12/11/2015
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
POC Study in Partially Responsive Generalized Anxiety Disorder
Updated: 12/11/2015
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
Updated: 12/11/2015
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
POC Study in Partially Responsive Generalized Anxiety Disorder
Updated: 12/11/2015
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
Updated: 12/11/2015
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
POC Study in Partially Responsive Generalized Anxiety Disorder
Updated: 12/11/2015
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
Updated: 12/11/2015
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
POC Study in Partially Responsive Generalized Anxiety Disorder
Updated: 12/11/2015
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Click here to add this to my saved trials